West Pharmaceutical Services Inc
WST· NYSE
Released Jul 29, 2021, before the open
10-Q filed Jul 30, 2021, 30 days after period end · 0000105770-21-000055
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $723.60M | $527.20M | $469.70M | $447.50M |
| Net Income | $187.30M | $91.20M | $66.10M | $56.10M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $2.47 |
| $1.21 |
| $0.88 |
| $0.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.